Skip to main content
. 2010 Feb 16;102(5):922–929. doi: 10.1038/sj.bjc.6605569

Figure 2.

Figure 2

(A) Example of immunostaining for matrix metalloproteinase (MMP)-14 in prostate benign pathology. Magnification: × 200. (B) Example of immunostaining for MMP-14 in prostate carcinoma. Magnification: × 200.